Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Carolin Bokelmann has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ensuring Good Transferability from Pilot- to Large-Scale Optimized Biotech Bubble Column Designs

    by Carolin Link, Jason Bromley, Michael Martin, Ralf Takors

    Scaling biotechnology processes such as gas fermentation remains resource- and time-intensive, both experimentally and in modeling. To improve the efficiency of reactor geometry optimization, we evaluated the transferability of findings from pilot-scale (950 L) simulations to industrial-scale simulations (950 m3). At constant geometric ratios and aeration (vvm) across scales, highly similar flow patterns were observed, especially in airlift reactors. Reactor design enhancements at the pilot scale were transferable to the industrial scale, delivering improvements of up to 17% for kLa. Surprisingly, the commercial simulation resulted in an order-of-magnitude-higher gas holdup and kLa than the pilot, owing to a longer bubble residence time in the taller vessel. Thus, transferability can be further enhanced by enforcing constant superficial gas velocity between scales. This leads to more similar CO transfer rates and regime distributions inside the tank but will challenge reaching sufficient mass transfer for industrial applications.


  • Open Access

    Optimization of the Parameters of a Minimal Coagulation Model

    by Carolin Link, Gábor Janiga, Dominique Thévenin

    The formation of a blood clot within a vessel can result in its complete blockage. This phenomenon, known as thrombosis, can have severe consequences. In contrary, thrombosis can be sometimes desirable. Intra-aneurysmal thrombosis is the primary objective of an endovascular treatment aimed at occluding the aneurysm sac. The proper modeling of the coagulation system is, therefore, important for the prediction, early recognition, and prevention of these tendencies. In silico investigations based on computational fluid dynamics (CFD) extended by thrombosis models provide a valuable tool for a detailed analysis. Minimal models are particularly useful for practical purposes to reduce computational efforts. This work proposes an approach to adapt the parameters of a minimal model to reproduce the behavior obtained with a comprehensive description of the coagulation cascade. The objective is to obtain the same thrombin generation curves while reducing strongly computational costs. For this purpose, machine learning—based here on an evolutionary algorithm—is used to optimize the obtained agreement. By adapting the reaction rate coefficients, a significant improvement can be achieved. The obtained results pave the way for future applications of the improved model in complex configurations such as for planning personalized interventions. Notably, the minimal model will be used for CFD in future studies to take advantage of its low computational cost.

  • Open Access

    Dos and don’ts for scaling up gas fermentations

    by Lars Puiman, Carolin Bokelmann, Sean D Simpson, Alfred M Spormann, Ralf Takors


  • Open Access

    Deciphering Metabolic Pathways in High-Seeding-Density Fed-Batch Processes for Monoclonal Antibody Production: A Computational Modeling Perspective

    by Carolin Bokelmann, Alireza Ehsani, Jochen Schaub, Fabian Stiefel

    Due to their high specificity, monoclonal antibodies (mAbs) have garnered significant attention in recent decades, with advancements in production processes, such as high-seeding-density (HSD) strategies, contributing to improved titers. This study provides a thorough investigation of high seeding processes for mAb production in Chinese hamster ovary (CHO) cells, focused on identifying significant metabolites and their interactions. We observed high glycolytic fluxes, the depletion of asparagine, and a shift from lactate production to consumption. Using a metabolic network and flux analysis, we compared the standard fed-batch (STD FB) with HSD cultivations, exploring supplementary lactate and cysteine, and a bolus medium enriched with amino acids. We reconstructed a metabolic network and kinetic models based on the observations and explored the effects of different feeding strategies on CHO cell metabolism. Our findings revealed that the addition of a bolus medium (BM) containing asparagine improved final titers. However, increasing the asparagine concentration in the feed further prevented the lactate shift, indicating a need to find a balance between increased asparagine to counteract limitations and lower asparagine to preserve the shift in lactate metabolism.


  • Open Access

    Deciphering Metabolic Pathways in High Seeding Density Fed-Batch Processes for Monoclonal Antibody Production: A Computational Modeling Perspective

    by Carolin Bokelmann, Alireza Ehsani, Jochen Schaub, Fabian Stiefel

    Due to their high specificity, monoclonal antibodies (mAbs) have garnered significant attention in recent decades, with advancements in production processes, such as high seeding density (HSD) strategies, contributing to improved titers. This study provides a thorough investigation of high seeding processes for mAb production in Chinese hamster ovary (CHO) cells. Using a metabolic network and flux balance analysis, we compared standard fed-batch (STD FB) with HSD cultivations, exploring supplementary lactate and cysteine, and a bolus medium enriched in amino acids. We observed high glycolytic fluxes and depletion of asparagine simultaneously with the lactate shift building kinetic models around this and other observations. An ensemble of kinetic models assessed the impact of a feeding medium enriched with additional asparagine, revealing a missing lactate shift without enhancing mAb productivity in the experiments. This research provides valuable model-based insights into cellular metabolism during HSD processes, laying the foundation for refined CHO cell-based mAb production. The proposed hypothesis on the regulations guides future experimental validation and bioprocess optimization for enhanced mAb production efficiency.